---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-004066"
form_type: "8-K"
ticker: "XBIT"
cik: "0001626878"
company_name: "XBiotech Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:39:59.744138+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# XBiotech appoints Dr. Thomas Kündig and Craig Rademaker to Board of Directors

## Summary
- Dr. Thomas Kündig, Director of Dermatology at University Hospital Zurich, appointed to Board and Compensation Committee effective June 24, 2025.
- Craig Rademaker, private equity leader with 25+ years in finance, appointed to Board and Audit Committee, effective same date.
- Both appointments expire at the 2025 Annual General Meeting; committees now include Jan-Paul Waldin, Dr. Peter Libby, and the new members.

## SEC filing metadata
- accession: 0001171843-25-004066
- form_type: 8-K
- ticker: XBIT
- cik: 0001626878
- company_name: XBiotech Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626878/000117184325004066/0001171843-25-004066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626878/000117184325004066/f8k_062425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-004066
- JSON: https://secwatch.observer/filing/0001171843-25-004066.json
- Plain text: https://secwatch.observer/filing/0001171843-25-004066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.